Key result
Vagus nerve stimulation improves symptoms, functional capacity, and LVEF in patients with HFrEF.
Why the study?
Does autonomic regulation therapy using vagus nerve stimulation improve symptoms and cardiac function in patients living with heart failure and reduced ejection fraction?
Does autonomic regulation therapy using vagus nerve stimulation improve symptoms and cardiac function in patients living with heart failure and reduced ejection fraction?
Autonomic regulation therapy using vagus nerve stimulation shows promise in improving cardiac function and symptoms in HFrEF patients, warranting ongoing large-scale randomized trials.
Supports vagus nerve stimulation evaluation in HFrEF; leaves open randomized confirmation before practice change.
The ANTHEM-HF, INOVATE-HF, and NECTAR-HF clinical studies of autonomic regulation therapy (ART) using vagus nerve stimulation (VNS) systems have collectively provided dose-ranging information enabling the development of several working hypotheses on how stimulation frequency can be utilized during VNS for tolerability and improving cardiovascular outcomes in patients living with heart failure (HF) and reduced ejection fraction (HFrEF). Changes in heart rate dynamics, comprising reduced heart rate (HR) and increased HR variability, are a biomarker of autonomic nerve system engagement and cardiac control, and appear to be sensitive to VNS that is delivered using a stimulation frequency that is similar to the natural operating frequency of the vagus nerve. Among prior studies, the ANTHEM-HF Pilot Study has provided the clearest evidence of autonomic engagement with VNS that was delivered using a stimulation frequency that was within the operating range of the vagus nerve. Achieving autonomic engagement was accompanied by improvement from baseline in six-minute walk duration (6MWD), health-related quality of life, and left ventricular EF (LVEF), over and above those achieved by concomitant guideline-directed medical therapy (GDMT) administered to counteract harmful neurohormonal activation, with relative freedom from deleterious effects. Autonomic engagement and positive directional changes have persisted over time, and an exploratory analysis suggests that improvement in autonomic tone, symptoms, and physical capacity may be independent of baseline NT-proBNP values. Based upon these encouraging observations, prospective, randomized controlled trials examining the effects on symptoms and cardiac function as well as natural history have been warranted. A multi-national, large-scale, randomized, controlled trial is well underway to determine the outcomes associated with ART using autonomic nervous system engagement as a guide for VNS delivery.
No takes yet. Share an insight, caveat, or question.
Konstam et al. (2022) conducted a review in Heart Failure with reduced Ejection Fraction (HFrEF). Autonomic Regulation Therapy (ART) using Vagus Nerve Stimulation (VNS) vs. Guideline Directed Medical Therapy (GDMT) was evaluated. Autonomic regulation therapy using vagus nerve stimulation delivered at the natural operating frequency of the vagus nerve improves symptoms, functional capacity, and left ventricular ejection fraction in patients with heart failure and reduced ejection fraction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: